VivoSeq
Gastroenterology

Chronic Liver Disease

1

Pipeline Programs↗

2

Active Trials↗

1

Companies Involved↗

Chronic Liver Disease is an early-stage landscape with 1 program across 1 company. The most active players are Daewoong Pharmaceutical Co. LTD..

Intelligence

Pipeline Metrics

Competitive Density

16/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

N/A

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Daewoong Pharmaceutical Co. LTD. logo

Daewoong Pharmaceutical Co. LTD.

1 program

Preclinical

Pipeline

Programs by Phase

Preclinical1

Ursodeoxycholic Acid

Daewoong Pharmaceutical Co. LTD.

Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Approved
No programs

Analysis

Trial Status

2

clinical trials

Not yet recruiting2 · 100%

Clinical Trials

Trial Activity

Influence of Donor and Recipient PNPLA3 and MBOAT7 Gene Polymorphisms on Graft Liver Steatosis After Living Donor Liver Transplant for Metabolic Dysfunction-associated Steatohepatitis (MASH) Related Cirrhosis
Not yet recruiting·IInstitute of Liver and Biliary Sciences, India·N/A·NCT07685353·50 enrolled
Effect of Ursodeoxycholic Acid Supplementation on Liver Regeneration in Adult Living Donor Liver Transplant (LDLT) Recipients : A Placebo Controlled Randomised Trial
Not yet recruiting·IInstitute of Liver and Biliary Sciences, India·Preclinical·NCT07664020·130 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)